Trial Profile
Clinical trial of effects of alogliptin bensoate on endothelial function in type II diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Nov 2019 Status changed from active, no longer recruiting to completed.
- 02 May 2019 Results (n=22) published in the American Journal of Hypertension
- 25 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.